| Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559) |
|---|
| 02/14/2013 | US20130040983 Raf kinase inhibitors |
| 02/14/2013 | US20130040981 Pyridylvinylpyrazoloquinolines as PAR1 inhibitors |
| 02/14/2013 | US20130040977 Pro-Neurogenic Compounds |
| 02/14/2013 | US20130040973 JAK PI3K/mTOR COMBINATION THERAPY |
| 02/14/2013 | US20130040949 Type ii raf kinase inhibitors |
| 02/14/2013 | US20130040943 Tricyclic pyridyl-vinyl pyrroles as par1 inhibitors |
| 02/14/2013 | US20130040941 Benzodiazepine compound and pharmaceutical composition |
| 02/14/2013 | US20130040933 Azaindoles as janus kinase inhibitors |
| 02/14/2013 | US20130040931 Amino Heteroaryl Compounds as Beta-Secretase Modulators and Methods of Use |
| 02/14/2013 | US20130040930 Novel amide derivative and use thereof as medicine |
| 02/14/2013 | US20130040914 Prodrugs of an hiv reverse transcriptase inhibitor |
| 02/14/2013 | US20130040892 Iap bir domain binding compounds |
| 02/14/2013 | US20130039987 Method for increasing the solubility of a transcriptase inhibitor composition |
| 02/14/2013 | US20130039906 PYRAZOLO[3,4-c]PYRIDINE COMPOUNDS AND METHODS OF USE |
| 02/14/2013 | US20130039870 Cosmetic Or Dermatological Preparations With A Content Of One Or More Thiazole Derivates |
| 02/14/2013 | CA2844588A1 Pyrido-pyrimidine derivatives |
| 02/14/2013 | CA2844525A1 Cyclopropaneamine compound |
| 02/14/2013 | CA2842531A1 Antibacterial piperidinyl substituted 3,4-dihydro-1h-[1,8]naphthyridinones |
| 02/14/2013 | CA2842526A1 Antibacterial homopiperidinyl substituted 3,4-dihydro-1h-[1,8]naphthyridinones |
| 02/14/2013 | CA2842518A1 Antibacterial cyclopenta[c]pyrrole substituted 3,4-dihydro-1h-[1,8]naphthyridinones |
| 02/13/2013 | EP2556856A1 6-Cyano-substituted Pyrido[2,3-d]pyrimidines as Adenosin Rezeptor Ligands for the Treatment of Cardiovascular Diseases |
| 02/13/2013 | EP2556831A1 3,4-Dihydro-4-oxo-5-aryl-pyrido[2,3-d]pyrimidine-6-carbonitriles as Adenosin Receptor Ligands for Treatment of Cardiovascular Diseases |
| 02/13/2013 | EP2556073A1 Bicyclic pyrimidinyl pyrazoles |
| 02/13/2013 | EP2555617A1 Novel hypoglycemic compounds |
| 02/13/2013 | CN102933581A Thionated aromatic bisimides as organic semiconductors and devices incorporating them |
| 02/13/2013 | CN102933575A Yclohexyl-azetidinyl antagonists of ccr2 |
| 02/13/2013 | CN102933571A Phthalazin-(2h)-one inhibitors of kinases |
| 02/13/2013 | CN102925529A Method for producing intermediate of levo-praziquantel and levo-praziquantel |
| 02/13/2013 | CN102925528A Method for producing intermediate of levo-praziquantel and levo-praziquantel |
| 02/13/2013 | CN102924458A 6,6-bicyclic ring substituted heterobicyclic protein kinase inhibitors |
| 02/13/2013 | CN102924452A Synthesis method of 5, 6, 7, 8-tetrahydro-2H-pyrido[3, 4-c]pyridazine-3-ketone |
| 02/13/2013 | CN102924451A Preparing method of o-phenanthroline complexing agents |
| 02/13/2013 | CN102924450A 6-(5-pyridyl)-1,2,4-triazolopyridine compound, and preparation method and application thereof |
| 02/13/2013 | CN102924449A H crystal form of moxifloxacin hydrochloride, preparation method thereof and medical composition |
| 02/13/2013 | CN102924448A Alkaloid cryptolepine analogue quindoline acid compound and preparation method |
| 02/13/2013 | CN102924447A Compound having pyridoindole ring structure having substituted pyridyl group attached thereto, and organic electroluminescence element |
| 02/13/2013 | CN102924445A PIM kinase inhibitor, preparation method thereof, and application thereof in pharmacy |
| 02/13/2013 | CN102924384A Derivatives having vinyl group and its use in electroluminescent element |
| 02/13/2013 | CN102924217A Fluorene and pyrene derivatives and organic electroluminescent device using the same |
| 02/13/2013 | CN102382112B Compound for curing tumors, preparation method and application thereof |
| 02/13/2013 | CN102001985B Fullerene multi-nitrogen heterocyclic water-soluble derivatives as well as preparation method and application thereof |
| 02/13/2013 | CN101792442B Production method based on harmel alkaloid physical and chemical properties |
| 02/12/2013 | US8372981 Nitrogen-containing aromatic derivatives |
| 02/12/2013 | US8372970 8-ethyl-6-(aryl)pyrido[2,3-D]pyrimidin-7(8H)-ones for the treatment of CNS disorders |
| 02/12/2013 | US8372860 Carboline derivatives useful in the inhibition of angiogenesis |
| 02/12/2013 | US8372842 Pyrazolopyridines as kinase inhibitors |
| 02/12/2013 | US8372832 1,4-diaza-bicyclo[3.2.2]nonyl oxadiazolyl compounds and their medical use |
| 02/12/2013 | US8372527 Material for organic electroluminescent element, and organic electroluminescent element |
| 02/07/2013 | WO2013019828A1 Inhibitors of influenza viruses replication |
| 02/07/2013 | WO2013018928A1 Fused heterocyclic compound and use thereof for pest control |
| 02/07/2013 | WO2013018899A1 Dibenzooxepin derivative |
| 02/07/2013 | WO2013018733A1 1,5-naphthyridine derivative or salt thereof |
| 02/07/2013 | WO2013018374A1 Ketone derivative and drug containing same |
| 02/07/2013 | WO2013018372A1 Amide derivative and drug containing same |
| 02/07/2013 | WO2013018371A1 Biaryl ester derivative and drug containing same |
| 02/07/2013 | WO2013017678A1 Novel spiroindoline compounds |
| 02/07/2013 | WO2013017657A1 Phenyl-3-aza-bicyclo[3.1.0]hex-3-yl-methanones and the use thereof as medicament |
| 02/07/2013 | WO2013017480A1 Pyrazolo[4,3-c]pyridine derivatives as jak inhibitors |
| 02/07/2013 | WO2013017479A1 Pyrazolo[4,3-c]pyridine derivatives as jak inhibitors |
| 02/07/2013 | WO2013016999A1 Heteroaryl-pyrimidine derivatives, and preparation method therefor and use thereof |
| 02/07/2013 | WO2012111579A9 Light-emitting element |
| 02/07/2013 | WO2012073041A3 Inhibitors of apurinic/apyrimidinic endonuclease 1 (ape1) and their use |
| 02/07/2013 | US20130035354 Aryl pyridine as aldosterone synthase inhibitors |
| 02/07/2013 | US20130035346 Amide derivatives bearing a cyclopropylaminoacarbonyl substituent useful as cytokine inhibitors |
| 02/07/2013 | US20130035339 Apoptosis signal-regulating kinase inhibitors |
| 02/07/2013 | US20130035337 Fused bicyclic heteroaryl derivative |
| 02/07/2013 | US20130035335 8-ethyl-6-(aryl)pyrido[2,3-d]pyrimidin-7(8h)-ones for the treatment of cns disorders |
| 02/07/2013 | US20130035329 Therapeutically active compositions and their methods of use |
| 02/07/2013 | US20130035327 Modulators of ATP-Binding Cassette Transporters |
| 02/07/2013 | US20130035326 Biaryl compounds and methods of use thereof |
| 02/07/2013 | US20130035325 Kinase inhibitors |
| 02/07/2013 | US20130035324 Heterocyclic compounds and uses thereof |
| 02/07/2013 | US20130032787 Heterocyclic compound and organic light-emitting device including the same |
| 02/07/2013 | CA2844241A1 Fused heterocyclic compound and use thereof for pest control |
| 02/07/2013 | CA2844054A1 Inhibitors of influenza viruses replication |
| 02/07/2013 | CA2843805A1 Phenyl-3-aza-bicyclo[3.1.0]hex-3-yl-methanones and the use thereof as medicament |
| 02/06/2013 | EP2554533A1 Rare-earth metal complex |
| 02/06/2013 | EP2554163A1 Neurodegenerative disease therapeutic agent |
| 02/06/2013 | EP2552915A1 Compounds and method for treatment of hiv |
| 02/06/2013 | EP2552914A1 Benzonaphthyridinamines as autotaxin inhibitors |
| 02/06/2013 | EP2552908A2 Heterocyclic compounds and their uses |
| 02/06/2013 | EP2552893A1 Antibacterial isoquinolin-3-ylurea derivatives |
| 02/06/2013 | EP2552211A1 Indazolyl-pyrimidines as kinase inhibitors |
| 02/06/2013 | CN102918039A Oral formulations and lipophilic salts of methylnaltrexone |
| 02/06/2013 | CN102917700A Neurodegenerative disease therapeutic agent |
| 02/06/2013 | CN102911996A Method for preparing levo-praziquantel |
| 02/06/2013 | CN102911979A Method for preparing levo-praziquantel |
| 02/06/2013 | CN102911174A Synthesis method of 1H-pyrazolo (4, 3-b) pyridine-3-carboxylic acid ethyl ester and 6-bromine-substituted compound thereof |
| 02/06/2013 | CN102911173A Synthetic method of 5,6,7,8-tetrahydro-2H-pyridino-[4,3-c]pyridazine-3-ketone |
| 02/06/2013 | CN102911172A Heteroaryl pyrimidine derivatives and preparation method and application thereof |
| 02/06/2013 | CN102911112A Heterocyclic compound and organic light-emitting device including the same |
| 02/06/2013 | CN102382111B Sulfo-tetrahydro-pyridino-dihydro-pyrimidone derivative, preparation method for same and application thereof |
| 02/06/2013 | CN102050841B 2-propionamide-1,10-phenanthroline anil coordination compound, preparation method thereof, catalyst comprising same and application thereof |
| 02/06/2013 | CN101679272B Triazolo [1, 5-a] quinolines as adenosine A3 receptor ligands |
| 02/06/2013 | CN101528743B Fused heterocyclic derivatives and methods of use |
| 02/06/2013 | CN101389632B Spiroketals |
| 02/05/2013 | US8368062 Nitrogen-containing heterocyclic compound and organic electronic device using the same |
| 02/05/2013 | US8367831 Heterocyclic compound or salt thereof and intermediate thereof |
| 02/05/2013 | US8367830 Methods for the identification of phosphatidylinositol kinase interacting molecules and for the purification of phosphatidylinositol kinase proteins |
| 02/05/2013 | US8367828 PPAR active compounds |